{"id":159070,"date":"2024-10-22T15:17:18","date_gmt":"2024-10-22T15:17:18","guid":{"rendered":"https:\/\/news.talkwithrattan.com\/index.php\/2024\/10\/22\/once-weekly-insulin-might-mean-fewer-shots-for-some-with-diabetes\/"},"modified":"2024-10-22T15:17:18","modified_gmt":"2024-10-22T15:17:18","slug":"once-weekly-insulin-might-mean-fewer-shots-for-some-with-diabetes","status":"publish","type":"post","link":"https:\/\/news.talkwithrattan.com\/index.php\/2024\/10\/22\/once-weekly-insulin-might-mean-fewer-shots-for-some-with-diabetes\/","title":{"rendered":"Once-weekly insulin might mean fewer shots for some with diabetes"},"content":{"rendered":"
\"Once-weekly<\/div> \r\n

\n\t\t\t\t\n\n\n\n\n

Life with diabetes usually includes many injections of the blood sugar\u2013controlling hormone insulin. Recent research investigating a once-weekly shot finds it might help lessen the burden a bit for some with the disease.<\/p>\n\n\n\n

Two pharmaceutical companies have developed weekly insulin formulations and have tested the drugs in late-stage clinical trials. This September, in the New England Journal of Medicine<\/em>, researchers reported promising results for efsitora<\/a>, from Eli Lilly. For adults with type 2 diabetes, the drug worked as well as a once-daily formulation of insulin. But a trial of adults with type 1 diabetes, reported the same month in the Lancet<\/em>, found there were more episodes of dangerously low blood sugar in the group on efsitora<\/a> than in the group taking a once-daily insulin shot.<\/p>\n\n\n